Q13093 (PAFA_HUMAN) Homo sapiens (Human)
Platelet-activating factor acetylhydrolase UniProtKBInterProSTRINGInteractive Modelling
441 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
33 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal structure of human plasma platelet activating factor acetylhydrolase covalently inhibited b… | monomer | 1×NTJ; 31×FMT; | ||||
| Assess | ||||||
| The crystal structure of Lp-PLA2 in complex with a novel inhibitor | monomer | 1×8U6; 3×SO4; | ||||
| Assess | ||||||
| Crystal structure of human plasma platelet activating factor acetylhydrolase covalently inhibited b… | monomer | 1×DEP; 7×FMT; | ||||
| Assess | ||||||
| Crystal structure of human plasma platelet activating factor acetylhydrolase | monomer | 17×ACT; | ||||
| Assess | ||||||
| Crystal structure of human plasma platelet activating factor acetylhydrolase covalently inhibited b… | monomer | 1×GD7; | ||||
| Assess | ||||||
| The crystal structure of Lp-PLA2 in complex with a novel inhibitor | monomer | 2×SO4; 1×8U9; | ||||
| Assess | ||||||
| Crystal structure of human plasma platelet activating factor acetylhydrolase covalently inhibited b… | monomer | 1×DFP; | ||||
| Assess | ||||||
| The crystal structure of Lp-PLA2 in complex with a novel inhibitor | monomer | 1×8U3; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 2×CL; 1×DMS; 1×6HU; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 1×CL; 1×DMS; 1×6HR; | ||||
| Assess | ||||||
| Compound binding to Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA2)discovered through fragm… | monomer | 1×MG; 1×CL; 1×DMS; 1×FB2; | ||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 2×CL; 1×7K4; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 1×MG; 2×CL; 1×DMS; 1×6HO; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 1×CL; 1×6HQ; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 2×CL; 1×DMS; 1×6HW; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 1×CA; 1×CL; 1×DMS; 1×6HX; | ||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 2×CL; 1×7BW; | ||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 1×NA; 1×CL; 1×7BX; | ||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 1×CL; 1×7BK; | ||||
| Assess | ||||||
| Crystal structure of Lp-PLA2 in complex with a novel covalent inhibitor | monomer | 1×BWF; | ||||
| Assess | ||||||
| Crystal structure of human plasma platelet activating factor acetylhydrolase covalently inhibited b… | monomer | |||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 2×CL; 1×7BP; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 1×DMS; 2×CL; 1×6HV; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 2×CL; 1×CA; 1×6HP; | ||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 1×7BJ; | ||||
| Assess | ||||||
| The crystal structure of Lp-PLA2 in complex with a novel inhibitor | monomer | 1×8U0; 1×SO4; | ||||
| Assess | ||||||
| Exploitation of a Novel Binding Pocket in Human Lipoprotein-Associated Phospholipase A2 (Lp-PLA<sub… | monomer | 1×CA; 1×CL; 1×DMS; 1×6HZ; | ||||
| Assess | ||||||
| Crystal structure of LP_PLA2 in complex with Darapladib | monomer | 1×5HV; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 IN COMPLEX WITH A [1.1.1]BICYCLO… | monomer | 2×CL; 1×71H; | ||||
| Assess | ||||||
| Fragment-based inhibitors of Lipoprotein associated Phospholipase A2 | monomer | 1×CL; 1×NA; 1×7BR; | ||||
| Assess | ||||||
| Crystal structure of Lp-PLA2 in complex with a novel covalent inhibitor. | monomer | |||||
| Assess | ||||||
| Crystal structure of LP_PLA2 in complex with novel inhibitor | monomer | 1×VQ7; | ||||
| Assess | ||||||
| Crystal structure of Lp-PLA2 in complex with a novel covalent inhibitor | monomer | 1×BWO; | ||||
| Assess | ||||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3d5e.1.A | monomer | 0.91 | 1×DEP; | 100.00 | ||
| Assess | ||||||